PANTOPRAZOLE SODIUM | N022020 | WYETH PHARMACEUTICALS LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Foley & Lardner LLP FDA-2019-P-5535 · 5 docket documents Foley & Lardner LLP filed this petition under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA determine an ANDA may be submitted for pantoprazole sodium delayed-release oral suspension in 20 mg and 40 mg strengths packaged in unit dose capsules in bottles of | Other | 2019-11-22 | Open | Foley & Lardner LLP |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$14.10
per ea
Lowest NADAC/Unit
$14.10
per ea
Brand NDCs
1
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00008084402PROTONIX 40 MG SUSPENSION | $14.10 | EA | Brand | $4.39 | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7544370 | Jun 7, 2026PED: Dec 7, 2026 | PED | — | Yes | — | — |